Renamed to Revvity (NYSE:RVTY) in July 2023
PKI - PerkinElmer, Inc.
NYSE
->
Healthcare
->
Diagnostics & Research
Waltham,
United States
Type: Equity
PKI price evolution
PKI
| (in millions $) | 1 Feb 2023 | 2 Nov 2022 | 3 Aug 2022 | 3 May 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2267.18 | $454.36 | $400.74 | $360.86 |
| Short term investments | $193.96 | |||
| Net receivables | $612.78 | $540.87 | $932.13 | $941.72 |
| Inventory | $405.46 | $378.26 | $624.3 | $645.92 |
| Total current assets | $3288.56 | $3116.48 | $2107.77 | $2454.51 |
| Long term investments | ||||
| Property, plant & equipment | $671.3 | $620.52 | $742.98 | $749 |
| Goodwill & intangible assets | $9800.61 | $9858.94 | $9774.47 | $11014.71 |
| Total noncurrent assets | $10842.55 | $10841.3 | $10707.28 | $12081.93 |
| Total investments | $193.96 | |||
| Total assets | $14129.85 | $13823.76 | $14189.71 | $14848.47 |
| Current liabilities | ||||
| Accounts payable | $272.83 | $275.82 | $333.71 | $376.69 |
| Deferred revenue | ||||
| Short long term debt | $479.42 | $470.93 | $503.55 | $4.18 |
| Total current liabilities | $1544.48 | $1485.73 | $1043.81 | $1263.05 |
| Long term debt | $3923.35 | $3898.27 | $4484.31 | $4863.98 |
| Total noncurrent liabilities | $5040.61 | $5202.5 | $5272.83 | $5978.74 |
| Total debt | $4509.8 | $4564.24 | $4544.66 | $4671.48 |
| Total liabilities | $6746.98 | $6758.56 | $7022.55 | $7662.12 |
| Shareholders' equity | ||||
| Retained earnings | $4951.02 | $4834.05 | $4756.57 | $4585.23 |
| Other shareholder equity | -$447.46 | $7065.2 | $7167.15 | -$246.66 |
| Total shareholder equity | $8033.81 | $7382.88 | $7065.2 | $7167.15 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $454.36 | $618.32 | $402.04 | $191.88 |
| Short term investments | ||||
| Net receivables | $612.78 | $1023.79 | $1155.11 | $725.18 |
| Inventory | $405.46 | $624.71 | $514.57 | $356.94 |
| Total current assets | $3288.56 | $2440.78 | $2238.92 | $1374.38 |
| Long term investments | ||||
| Property, plant & equipment | $671.3 | $753.38 | $575.54 | $485.5 |
| Goodwill & intangible assets | $9858.94 | $11479.69 | $4812.81 | $4394.51 |
| Total noncurrent assets | $10841.3 | $12559.77 | $5721.4 | $5164.19 |
| Total investments | ||||
| Total assets | $14129.85 | $15000.55 | $7960.31 | $6538.56 |
| Current liabilities | ||||
| Accounts payable | $272.83 | $355.46 | $327.32 | $235.85 |
| Deferred revenue | ||||
| Short long term debt | $470.93 | $4.24 | $380.95 | $9.97 |
| Total current liabilities | $1544.48 | $1213.74 | $1652.19 | $762.83 |
| Long term debt | $3923.35 | $5165.1 | $1798.1 | $2210.44 |
| Total noncurrent liabilities | $5202.5 | $6645.56 | $2572.63 | $2961.91 |
| Total debt | $4564.24 | $5169.34 | $2179.05 | $2220.41 |
| Total liabilities | $6746.98 | $7859.31 | $4224.82 | $3724.74 |
| Shareholders' equity | ||||
| Retained earnings | $4951.02 | $4417.17 | $3507.26 | $2811.97 |
| Other shareholder equity | -$447.46 | -$162.69 | -$31.96 | -$199.65 |
| Total shareholder equity | $7382.88 | $7141.24 | $3735.49 | $2813.82 |
| (in millions $) | 1 Feb 2023 | 2 Nov 2022 | 3 Aug 2022 | 3 May 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $741.21 | $711.8 | $1229.57 | |
| Cost of revenue | ||||
| Gross Profit | $436.33 | $407.04 | $666.16 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $300.4 | $293.49 | $403.38 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $40.95 | $12.63 | $45.22 | |
| Interest expense | -$22.38 | -$30.37 | -$23.46 | |
| Net income | ||||
| Net income | $127.66 | $85.35 | $179.21 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2022 | 2 Feb 2022 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3311.82 | $3782.74 | $2883.67 | |
| Cost of revenue | $1321.99 | $1672.87 | $1487.62 | |
| Gross Profit | $1989.83 | $2109.88 | $1396.06 | |
| Operating activities | ||||
| Research & development | $221.62 | $205.39 | $189.34 | |
| Selling, general & administrative | $1025.51 | $917.89 | $815.32 | |
| Total operating expenses | $1247.13 | $1131.3 | $1034.08 | |
| Operating income | $742.7 | $978.58 | $361.97 | |
| Income from continuing operations | ||||
| EBIT | $799.2 | $978.5 | $361.97 | |
| Income tax expense | $139.16 | $178.4 | $9.58 | |
| Interest expense | $90.86 | $72.22 | $124.83 | |
| Net income | ||||
| Net income | $569.18 | $727.89 | $227.56 | |
| Income (for common shares) | $569.18 | $727.89 | $227.56 | |
| (in millions $) | 1 Feb 2023 | 2 Nov 2022 | 3 Aug 2022 | 3 May 2022 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$132.85 | -$107.17 | -$84.66 | -$56.31 |
| Financing activities | ||||
| Dividends paid | -$35.34 | -$26.5 | -$17.67 | -$8.84 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$661.8 | -$585.11 | -$519.47 | -$164.86 |
| Effect of exchange rate | -$33.75 | -$51.4 | -$33.98 | -$10.64 |
| Change in cash and equivalents | -$148.59 | -$203.02 | -$257.4 | $51.4 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | $569.18 | $943.16 | $727.89 | $227.56 |
| Operating activities | ||||
| Depreciation | $427 | $358 | $246.51 | $214.03 |
| Business acquisitions & disposals | $6.99 | -$3989.85 | -$407.21 | -$399.86 |
| Stock-based compensation | $51.52 | $32.78 | $29.13 | $31.51 |
| Total cash flows from operations | $679.81 | $1410.75 | $892.18 | $363.47 |
| Investing activities | ||||
| Capital expenditures | -$85.63 | -$99.89 | -$77.51 | -$76.33 |
| Investments | -$38.29 | -$23.13 | -$20.06 | -$6.39 |
| Total cash flows from investing | -$132.85 | -$4112.76 | -$504.5 | -$487.57 |
| Financing activities | ||||
| Dividends paid | -$35.34 | -$32.37 | -$31.21 | -$31.06 |
| Sale and purchase of stock | -$66.52 | -$47.95 | $30.73 | $13.42 |
| Net borrowings | -$559.17 | $3073.97 | -$187.47 | $198.99 |
| Total cash flows from financing | -$661.8 | $2941.66 | -$202.87 | $150.13 |
| Effect of exchange rate | -$33.75 | -$22.93 | $25.91 | -$0.45 |
| Change in cash and equivalents | -$148.59 | $216.72 | $210.72 | $25.58 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 126.30M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 67.15 |
| Cash/Share | 17.95 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.91 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.13 |
| Quick ratio | 1.87 |